Drawing for FSKILLOCUS

USPTO serial 78860575

FSKILLOCUS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
PERRY, KIMBERLY B
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with FSKILLOCUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gwenn Roos

GWENN ROOS LAW OFFICES OF GWENN ROOS26 BROOKDALE AVEWELLESLEY, MA 02482-1021UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
041Arranging and conducting educational conferences in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Arranging of seminars; Arranging of seminars and conferences in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Arranging professional workshop and training courses in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Business training in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Conducting seminars in the field of oncology; Conducting workshops and seminars in personal awareness; Conducting workshops and seminars in self awareness; Conducting workshops and seminars in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Developing educational manuals for others in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Development and dissemination of educational materials of others in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Education services, namely, providing tutoring in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Education services, namely, providing workshops, seminars, online tutorials and conferences in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Educational and entertainment services, namely, providing motivational and educational speakers in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Educational demonstrations in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Educational services namely conducting programs in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Educational services, namely, conducting workshops, seminars, online tutorials and conferences in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Instruction in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Medical training and teaching; Online journals, namely, blogs featuring education and training in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Organization of seminars, working groups, research groups and conventions, in the field of medicine; Providing continuing dental education courses; Providing continuing medical education courses in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Providing continuing nursing education courses; Publishing and distribution of books, reviews and other printed matter as well as related electronic data carriers in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Training for handling scientific instruments and apparatus for research in laboratories; Training services in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fields; Workshops and seminars in the field of pharmaceuticals, medicine and biotechnology, including sales in each of these fieldsACTIVEAug 20, 2001

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 25, 2007MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 25, 2007ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 25, 2007DOCKASSIGNED TO EXAMINER—
Mar 26, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2007CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 1, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 1, 2007SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 12, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 12, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 20, 2007IUAFUSE AMENDMENT FILED—
Jan 20, 2007EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 16, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2006NPUBNOTICE OF PUBLICATION—
Sep 8, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 1, 2006ALIEASSIGNED TO LIE—
Aug 28, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 22, 2006DOCKASSIGNED TO EXAMINER—
Apr 20, 2006MDSMNOTICE OF DESIGN SEARCH CODE MAILED—
Apr 19, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance